126 related articles for article (PubMed ID: 8763262)
1. Abnormal expression of the human CD44 gene in early colorectal malignancy with special reference to variant exon 9 (9v).
Kawahara K; Yoshino T; Kawasaki N; Miyake K; Akagi T
J Clin Pathol; 1996 Jun; 49(6):478-81. PubMed ID: 8763262
[TBL] [Abstract][Full Text] [Related]
2. Cellular distribution of CD44 gene transcripts in colorectal carcinomas and in normal colonic mucosa.
Gorham H; Sugino T; Woodman AC; Tarin D
J Clin Pathol; 1996 Jun; 49(6):482-8. PubMed ID: 8763263
[TBL] [Abstract][Full Text] [Related]
3. The adenoma-carcinoma sequence in the colorectum--early appearance of a hierarchy of small intestinal mucin antigen (SIMA) epitopes and correlation with malignant potential.
Pilbrow SJ; Hertzog PJ; Linnane AW
Br J Cancer; 1992 Oct; 66(4):748-57. PubMed ID: 1419617
[TBL] [Abstract][Full Text] [Related]
4. CD44-9v and CD44-10v are potential molecular markers for squamous cell carcinoma of the vulva.
Rodríguez-Rodríguez L; Sancho-Torres I; Gibbon DG; Watelet LF; Mesonero C
J Soc Gynecol Investig; 2000; 7(1):70-5. PubMed ID: 10732319
[TBL] [Abstract][Full Text] [Related]
5. CD44 expression in colorectal cancer.
Weg-Remers S; Schüder G; Zeitz M; Stallmach A
Ann N Y Acad Sci; 1998 Nov; 859():304-6. PubMed ID: 9928409
[No Abstract] [Full Text] [Related]
6. Expression of carbohydrate antigen 19-9 and stage-specific embryonic antigen 1 in nontumorous and tumorous epithelia of the human colon and rectum.
Gong E; Hirohashi S; Shimosato Y; Watanabe M; Ino Y; Teshima S; Kodaira S
J Natl Cancer Inst; 1985 Sep; 75(3):447-54. PubMed ID: 2863413
[TBL] [Abstract][Full Text] [Related]
7. CD44 expression in benign and malignant colorectal polyps.
Neumayer R; Rosen HR; Reiner A; Sebesta C; Schmid A; Tüchler H; Schiessel R
Dis Colon Rectum; 1999 Jan; 42(1):50-5. PubMed ID: 10211520
[TBL] [Abstract][Full Text] [Related]
8. CD44V6 expression in human colorectal carcinoma.
Coppola D; Hyacinthe M; Fu L; Cantor AB; Karl R; Marcet J; Cooper DL; Nicosia SV; Cooper HS
Hum Pathol; 1998 Jun; 29(6):627-35. PubMed ID: 9635685
[TBL] [Abstract][Full Text] [Related]
9. CD44 splice variants as prognostic markers in colorectal cancer.
Wielenga VJ; van der Voort R; Mulder JW; Kruyt PM; Weidema WF; Oosting J; Seldenrijk CA; van Krimpen C; Offerhaus GJ; Pals ST
Scand J Gastroenterol; 1998 Jan; 33(1):82-7. PubMed ID: 9489913
[TBL] [Abstract][Full Text] [Related]
10. Tissue concentrations of CEA and CA 19-9 in the carcinogenesis of colorectal carcinoma exemplified by the adenoma-carcinoma sequence.
Fischbach W; Mössner J
Res Exp Med (Berl); 1988; 188(2):101-14. PubMed ID: 3163815
[TBL] [Abstract][Full Text] [Related]
11. De-novo expression of CD44 and survival in gastric cancer.
Mayer B; Jauch KW; Günthert U; Figdor CG; Schildberg FW; Funke I; Johnson JP
Lancet; 1993 Oct; 342(8878):1019-22. PubMed ID: 7692200
[TBL] [Abstract][Full Text] [Related]
12. A CD44 variant exon 6 epitope as a prognostic indicator in breast cancer.
Schumacher U; Horny HP; Horst HA; Herrlich P; Kaiserling E
Eur J Surg Oncol; 1996 Jun; 22(3):259-61. PubMed ID: 8654608
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence.
Baldus SE; Hanisch FG; Pütz C; Flucke U; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP
Histol Histopathol; 2002 Jan; 17(1):191-8. PubMed ID: 11813869
[TBL] [Abstract][Full Text] [Related]
14. Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans.
Imazeki F; Yokosuka O; Yamaguchi T; Ohto M; Isono K; Omata M
Gastroenterology; 1996 Feb; 110(2):362-8. PubMed ID: 8566581
[TBL] [Abstract][Full Text] [Related]
15. Comparison of CD44 expression in early colorectal carcinomas of the de novo and ex adenoma types.
Mueller JD; Heider KH; Oberhuber G; Mueller E; Bethke B; Stolte M; Höfler H
Virchows Arch; 1998 Nov; 433(5):407-14. PubMed ID: 9849854
[TBL] [Abstract][Full Text] [Related]
16. Cellular distribution of a colonic adenoma-associated antigen as defined by monoclonal antibody Adnab-9.
Tobi M; Maliakkal BJ; Alousi MA; Voruganti V; Shafiuddin M; Yang S; Gesell MS; An T; Hatfield JS; Fligiel S
Scand J Gastroenterol; 1992 Sep; 27(9):737-42. PubMed ID: 1411278
[TBL] [Abstract][Full Text] [Related]
17. Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis.
Mulder JW; Wielenga VJ; Polak MM; van den Berg FM; Adolf GR; Herrlich P; Pals ST; Offerhaus GJ
Gut; 1995 Jan; 36(1):76-80. PubMed ID: 7534253
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression.
Wielenga VJ; Heider KH; Offerhaus GJ; Adolf GR; van den Berg FM; Ponta H; Herrlich P; Pals ST
Cancer Res; 1993 Oct; 53(20):4754-6. PubMed ID: 7691404
[TBL] [Abstract][Full Text] [Related]
19. CD44v6 down-regulation is an independent prognostic factor for poor outcome of colorectal carcinoma.
Wang L; Liu Q; Lin D; Lai M
Int J Clin Exp Pathol; 2015; 8(11):14283-93. PubMed ID: 26823744
[TBL] [Abstract][Full Text] [Related]
20. Abnormal expression of CD44 variants in the exfoliated cells in the feces of patients with colorectal cancer.
Yamao T; Matsumura Y; Shimada Y; Moriya Y; Sugihara K; Akasu T; Fujita S; Kakizoe T
Gastroenterology; 1998 Jun; 114(6):1196-205. PubMed ID: 9609756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]